A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
Ontology highlight
ABSTRACT: Despite the nationwide availability of pharmacogenomic (PGx) guidelines in electronic medication surveillance systems in The Netherlands, PGx guided prescribing is still uncommon in primary care. We set out to investigate the adoption of pharmacist initiated PGx testing in primary care. Community pharmacists were offered a free PGx test covering 40 variants in 8 genes to test patients receiving an incident prescription (IRx) of a selection of 10 drugs. Results of the PGx test along with predicted phenotypes and a therapeutic recommendation based on the Dutch Pharmacogenetics Working Group (DPWG) guidelines were transferred to the pharmacist and physician. Adoption was defined as the percentage of eligible patients that received genotyping. From November 2014-July 2016, 200 patients were in
SUBMITTER: Bank PCD
PROVIDER: S-EPMC6777565 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA